Aerovate Therapeutics (NASDAQ:AVTE) Stock Price Down 3.9% Following Insider Selling

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report)’s share price dropped 3.9% on Wednesday after an insider sold shares in the company. The company traded as low as $28.23 and last traded at $28.44. Approximately 5,463 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 121,717 shares. The […]

Related Keywords

United States ,Benjamint Dake ,Georgea Eldridge , ,Tower Research Capital ,Aerovate Therapeutics Inc ,Citigroup Inc ,Jefferies Financial Group ,Nasdaq ,Wells Fargo Company ,Aerovate Therapeutics ,Get Free Report ,Research Capital ,Wells Fargo ,Aerovate Therapeutics Daily ,Nasdaq Avte ,Navte ,Medical ,Stocks ,Technicals ,